The 78 rating InvestorsObserver gives to Elevation Oncology Inc (ELEV) stock puts it near the top of the Biotechnology industry. In addition to scoring higher than 92 percent of stocks in the Biotechnology industry, ELEV’s 78 overall rating means the stock scores better than 78 percent of all stocks.
ELEV has an Overall Score of 78. Find out what this means to you and get the rest of the rankings on ELEV!